SleepAI

Company Overview

Snapshot

Founded in November 2024 by Shirel Attia, SleepAI operates with 1-10 employees. The company has raised $820,000 across one funding round from one investor. In December 2024, SleepAI secured Pre-Seed funding from eHealth Ventures.

Business overview

SleepAI develops an AI-based medical monitoring system for the accurate, accessible, and scalable detection of obstructive sleep apnea (OSA) and other sleep disorders. The company's core technology leverages oximetry signal analysis to diagnose all levels of OSA severity with clinical-grade accuracy comparable to polysomnography (PSG). This solution enables non-invasive, multi-night, at-home or in-hospital diagnosis, classification of sleep stages, and continuous patient monitoring. SleepAI targets the healthcare industry, serving markets that require advanced diagnostics and patient remote monitoring within the Health Tech & Life Sciences sector.

Strategic signal

In May 2025, SleepAI published a clinical validation study in onlinelibrary.wiley.com, demonstrating the effectiveness of its AI algorithms for diagnosing adult obstructive sleep apnea and sleep staging from oximetry and photoplethysmography. This validation is a critical signal for investors, confirming the clinical utility and scientific rigor of SleepAI's technology, which is essential for market adoption and regulatory approvals in the medical diagnostics space.

Company Intelligence Q&A

What is SleepAI's primary focus?

SleepAI focuses on developing an AI-based medical monitoring system for the detection of obstructive sleep apnea (OSA) and other sleep disorders.

When was SleepAI founded and by whom?

SleepAI was founded in November 2024 by Shirel Attia.

What was a key recent validation for SleepAI's technology?

In May 2025, SleepAI published a clinical validation study in onlinelibrary.wiley.com, confirming the effectiveness of its AI algorithms for diagnosing adult obstructive sleep apnea and sleep staging from oximetry and photoplethysmography.

Which investor participated in SleepAI's Pre-Seed funding round?

In December 2024, SleepAI secured Pre-Seed funding from eHealth Ventures, an Israeli venture capital firm specializing in digital health startups.

What technology does SleepAI utilize for sleep disorder detection?

SleepAI leverages oximetry signal analysis and deep learning algorithms to detect all levels of OSA severity and classify sleep stages with clinical-grade accuracy.